ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,416Medicare Part D Prescriptions Filled, Including Refills

Rank: 340 out of 2588

$504K Total Retail Price of All Prescriptions

Rank: 460 out of 2588

293 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 293 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

16% of this provider’s 293 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 9,684 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LEVOTHYROXINE SODIUM 572 536 1 2
SIMVASTATIN 435 410 2 1
FUROSEMIDE 419 406 3 5
WARFARIN SODIUM 329 305 4 10
OMEPRAZOLE 305 275 5 6
POTASSIUM CHLORIDE 294 293 6 15
METOPROLOL SUCCINATE 268 256 7 12
HYDROCHLOROTHIAZIDE 237 225 8 13
CITALOPRAM HBR 214 195 9 27
ATORVASTATIN CALCIUM 214 212 9 11
LISINOPRIL 213 201 11 3
HYDROCODONE-ACETAMINOPHEN 183 168 S3 12 7
CRESTOR 165 151 13 25
ATENOLOL 145 145 14 14
VENLAFAXINE HCL ER 127 127 15 125
LISINOPRIL-HYDROCHLOROTHIAZIDE 126 122 16 35
FLUTICASONE PROPIONATE 121 107 17 40
CLOPIDOGREL 120 120 18 30
TRAZODONE HCL 119 99 19 61
TRAMADOL HCL 115 107 20 19
METFORMIN HCL 105 100 21 8
AMLODIPINE BESYLATE 99 99 22 4
SERTRALINE HCL 97 80 23 26
DILTIAZEM ER 97 97 23 150
METOPROLOL TARTRATE 95 89 25 9
LOVASTATIN 88 88 26 34
SPIRIVA 86 86 27 56
LOSARTAN POTASSIUM 83 80 28 17
SPIRONOLACTONE 81 79 29 58
ALENDRONATE SODIUM 81 81 29 21
RANITIDINE HCL 80 68 31 37
PROAIR HFA 80 72 31 50
LOSARTAN-HYDROCHLOROTHIAZIDE 80 80 31 66
NEXIUM 80 69 31 41
PLAVIX 75 75 35 43
PAROXETINE HCL 74 66 36 71
TAMSULOSIN HCL 74 74 36 23
GLIPIZIDE XL 74 74 36 140
LANTUS 74 74 36 47
NIFEDIPINE ER 71 71 40 59
DONEPEZIL HCL 71 71 40 22
PRAVASTATIN SODIUM 70 56 42 16
GABAPENTIN 67 58 43 18
FLUOXETINE HCL 66 44 44 92
GEMFIBROZIL 64 64 45 123
TRAMADOL HCL-ACETAMINOPHEN 62 49 46 208
FINASTERIDE 62 51 46 97
PREDNISONE 57 56 48 42
ATENOLOL-CHLORTHALIDONE 57 44 48 198
ZETIA 57 55 48 69
DILTIAZEM 24HR ER 57 55 48 166
PREMARIN 56 56 R 52 247
ADVAIR DISKUS 56 51 52 48
ZOLPIDEM TARTRATE 55 39 54 24
GLIPIZIDE ER 55 55 54 73
KLOR-CON M20 53 43 56 52
XARELTO 53 53 56 513
DIGOXIN 51 49 58 38
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 1, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.